✦ LIBER ✦

Commentary on “Meta-analysis of six-month memantine trials in Alzheimer’s disease.” Memantine has negligible benefits in mild to moderate Alzheimer’s disease

✍ Scribed by David S. Knopman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Meta-analysis of 6-month memantine clini

✍ Rachelle S. Doody; Pierre N. Tariot; Eric Pfeiffer; Jason T. Olin; Stephen M. Gr 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Commentary on “Meta-analysis of six-mont

✍ Lon S. Schneider 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Memantine versus donepezil in mild to mo

✍ P. J. Modrego; N. Fayed; J. M. Errea; C. Rios; M. A. Pina; M. Sarasa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

Efficacy of Memantine by Baseline Diseas

✍ Tocco, Michael; Tocco, Michael; Hendrix, Suzanne; Miller, Michael L.; Pejovic, V 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Safety and efficacy of a galantamine/mem

✍ Oliver Peters; Wolfgang Maier; Christian Luckhaus; Johannes Kornhuber; Johannes 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Results of a placebo-controlled 6-month

✍ B. Reisberg; S. Ferris; K. Sahin; U. Windscheif; H.J. Möbius 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 310 KB